By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vaxart, Inc. 

600 Townsend Street
Suite 120E
San Francisco  California  94103  U.S.A.
Phone: 415-437-0132 Fax:




Company News
Vaxart Challenges Takeda (TKPYY) with Oral Norovirus Vaccine 8/8/2016 7:30:22 AM
Vaxart Initiates Clinical Development Of First Oral Norovirus Vaccine 8/2/2016 8:59:30 AM
Vaxart Initiates Clinical Development Of First Oral RSV Vaccine 6/28/2016 10:34:06 AM
Vaxart To Present At Jefferies 2016 Healthcare Conference 6/6/2016 11:27:27 AM
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines 3/25/2016 7:36:42 AM
Vaxart, Inc. Begins Preclinical Testing Of An Oral Zika Virus Vaccine 3/3/2016 10:50:32 AM
Vaxart, Inc. Appoints Samir Singh As Senior Vice President, Corporate Development And Strategy 2/9/2016 9:55:37 AM
Vaxart, Inc. To Present At Leerink Partners Global Healthcare Conference 2/4/2016 10:14:35 AM
Vaxart, Inc. Announces Enrollment Of First Patient In Influenza B Phase I Trial 12/17/2015 8:28:27 AM
Vaxart, Inc. Awarded $13.98 Million HHS-BARDA Contract To Support Advanced Development Of Influenza Tablet Vaccine 10/28/2015 11:17:57 AM